| S1346 |
Heparin sodium
|
Heparin sodium, a sulfated polysaccharide belonging to the family of glycosaminoglycans, has numerous important biological activities associated with its interaction with diverse proteins. Heparin is used as an anticoagulant primarily through its interaction with AT III by enhancing AT-IIImediated inhibition of blood coagulation factors, including thrombin and factor Xa. Heparin prevents the induction of autophagy.
|
-
Cell Rep Med, 2025, 6(10):102410
-
Bone Res, 2025, 13(1):37
-
Theranostics, 2025, 15(6):2597-2623
|
|
| S2196 |
Dabigatran
|
Dabigatran is a potent nonpeptide thrombin inhibitor with an IC50 of 9.3 nM in a cell-free assay.
|
-
Thromb Res, 2025, 255:109480
-
Thromb Haemost, 2025, 10.1055/a-2497-4213
-
Thromb Haemost, 2024, 10.1055/a-2483-0107
|
|
| S2154 |
Dabigatran (BIBR-1048) etexilate
|
Dabigatran Etexilate (BIBR-1048) is the prodrug of dabigatran, a potent, nonpeptidic small molecule that specifically and reversibly inhibits both free and clot-bound thrombin by binding to the active site of the thrombin molecule.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
Eur J Pharmacol, 2024, 985:177058
-
Sci Rep, 2022, 12(1):3955
|
|
| S2069 |
Argatroban (MCI-9038)
|
Argatroban (MCI-9038) is a potent and selective synthetic thrombin inhibitor, with Ki ranging from 5 nM to 39 nM, and it is used as an anticoagulant.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
Neural Regen Res, 2024, 19(2):434-439
-
Cancer Lett, 2023, 553:215983
|
|
| S5074 |
Argatroban Monohydrate
|
Argatroban (Argatroban hydrate, Argipidine,MCI-9038 Monohydrate) is a direct, selective thrombin inhibitor with anticoagulant effects.
|
-
Cancer Lett, 2023, 553:215983
-
Life Sci, 2021, 269:119073
|
|
| S5960 |
Dabigatran etexilate mesylate
|
Dabigatran etexilate mesylate (Pradaxa, BIBR 1048MS, Dabigatran etexilate methanesulfonate) is an orally active prodrug of Dabigatran which is a reversible and selective, direct thrombin inhibitor (DTI). Dabigatran selectively and reversibly inhibits human thrombin with Ki of 4.5 nM and thrombin-induced platelet aggregation with IC50 of 10 nM.
|
-
bioRxiv, 2020, 10.1101/2020.04.22.054981
|
|
| E5835New |
Heparin
|
Heparin is a highly sulfated polysaccharide primarily used as an anticoagulant, which works mainly by inhibiting thrombin (FIIa) and/or factor Xa (FXa). It is commonly used to prevent and treat thromboembolic conditions such as deep vein thrombosis and pulmonary embolism. It also plays roles in inflammation, angiogenesis, and growth factor signaling, with potential therapeutic applications in cancer treatment and allergic conditions.
|
|
|